Hidenori Mikamiyama

ORCID

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Venues

Journal of medicinal chemistry

ACS medicinal chemistry letters

This page only lists publications with an associated author ORCID identifier.

Publications

Toru Yamada, Kousuke Mihara, Taichi Ueda, Daisuke Yamauchi, Masaya Shimizu, Azusa Ando, Kei Mayumi, Zenzaburo Nakata, Hidenori Mikamiyama
Discovery and Hit to Lead Optimization of Macrocyclic Peptides as Novel Tropomyosin Receptor Kinase A Antagonists. Journal of medicinal chemistry 67 (13) (2024)
Toru Yamada, Kousuke Mihara, Taichi Ueda, Daisuke Yamauchi, Masaya Shimizu, Azusa Ando, Kei Mayumi, Zenzaburo Nakata, Hidenori Mikamiyama
Discovery and Hit to Lead Optimization of Macrocyclic Peptides as Novel Tropomyosin Receptor Kinase A Antagonists. Journal of medicinal chemistry 67 (13) (2024)
Toru Yamada, Kousuke Mihara, Taichi Ueda, Daisuke Yamauchi, Masaya Shimizu, Azusa Ando, Kei Mayumi, Zenzaburo Nakata, Hidenori Mikamiyama
Discovery and Hit to Lead Optimization of Macrocyclic Peptides as Novel Tropomyosin Receptor Kinase A Antagonists. Journal of medicinal chemistry (2024)
Yoshifumi Kusumoto, Kyohei Hayashi, Soichiro Sato, Toru Yamada, Iori Kozono, Zenzaburo Nakata, Naoya Asada, Shungo Mitsuki, Ayahisa Watanabe, Chiaki Wakasa-Morimoto, Kentaro Uemura, Shuhei Arita, Shinobu Miki, Tohru Mizutare, Hidenori Mikamiyama
Highly Potent and Oral Macrocyclic Peptides as a HIV-1 Protease Inhibitor: mRNA Display-Derived Hit-to-Lead Optimization. ACS medicinal chemistry letters 13 (10) (2022)
Kyohei Hayashi, Shota Uehara, Shiho Yamamoto, Douglas R Cary, Junichi Nishikawa, Taichi Ueda, Hiroki Ozasa, Kousuke Mihara, Norito Yoshimura, Taeko Kawai, Takashi Ono, Saki Yamamoto, Masataka Fumoto, Hidenori Mikamiyama
Macrocyclic Peptides as a Novel Class of NNMT Inhibitors: A SAR Study Aimed at Inhibitory Activity in the Cell. ACS medicinal chemistry letters 12 (7) (2021)

Hidenori Mikamiyama.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Hidenori Mikamiyama